Related Experiment Videos
Kinetic aspects of membrane-based immunoaffinity chromatography
1Department of Protein Biochemistry, Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110.
Journal of Chromatography
|April 24, 1992
Summary
This study reveals that adsorption kinetics, not mass transfer, limit membrane-based immunoaffinity chromatography (MIC) for recombinant protein purification. Optimizing antibody density enhances binding efficiency for biotherapeutics.
Area of Science:
- Biotechnology
- Protein Purification
- Chromatography
Background:
- Efficient large-scale purification of recombinant proteins is crucial for biopharmaceutical development.
- Membrane-based immunosorbents offer potential for high-capacity protein purification.
- Understanding adsorption kinetics is key to optimizing chromatographic processes.
Purpose of the Study:
- To investigate factors influencing antigen-antibody adsorption kinetics in hollow-fiber membrane immunosorbents.
- To determine the rate-limiting step in membrane-based immunoaffinity chromatography (MIC).
- To guide the development of efficient MIC systems for biotherapeutic purification.
Main Methods:
- Studied antigen-antibody adsorption kinetics in a model hollow-fiber membrane system.
- Analyzed the influence of antibody coupling density on binding efficiency.
- Investigated antigen breakthrough and binding capacity.
Main Results:
- Non-diffusion-controlled, homogeneous adsorption kinetics were observed in membranes.
- Adsorption kinetics, rather than mass transfer, were identified as the initial limiting factor in MIC.
- Antigen adsorption was not kinetically limited, even at low concentrations.
- Decreasing antibody coupling density improved binding efficiency.
- Antigen breakthrough occurred near the membrane's binding capacity.
Conclusions:
- Adsorption kinetics are critical for optimizing membrane-based immunoaffinity chromatography.
- Efficient MIC systems can be developed by understanding and controlling kinetic parameters.
- This research facilitated the development of productive MIC systems for interferon-alpha 2a, interleukin-2, and interleukin-2 receptor purification.